Cancer-associated anemia is thought to be partially mediated via an increase in inflammatory cytokines, like interleukin 6 or tumor necrosis factor alpha, that are believed to negatively interfere with iron metabolism [8,33]. This evidence concerns the gene IL6 and anemia (phenotype).